Insider Transactions in Q3 2017 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q3 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2017
|
Joseph C Caldarella SVP & Controller |
SELL
Open market or private sale
|
Direct |
9,340
-16.79%
|
$560,400
$60.0 P/Share
|
|
Sep 03
2017
|
Anne Nielsen Chief Compliance & Ethics Off |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-2.16%
|
$49,383
$59.81 P/Share
|
|
Sep 03
2017
|
Anne Nielsen Chief Compliance & Ethics Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,594
+3.95%
|
-
|
|
Aug 02
2017
|
Theodore R. Samuels Ii Director |
BUY
Open market or private purchase
|
Direct |
6,000
+25.0%
|
$330,000
$55.94 P/Share
|
|
Aug 01
2017
|
Murdo Gordon EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
783
-2.72%
|
$43,848
$56.1 P/Share
|
|
Aug 01
2017
|
Murdo Gordon EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,510
+4.99%
|
-
|